ArticleScientific reports2025
Label credibility correction based on cell morphological differences for cervical cells classification.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- AI in Cervical Cancer Cytology Diagnostics: A Narrative Review of Cutting-Edge Studies.Bioengineering (Basel, Switzerland) · 2025Review
- Machine Learning of Urine Cytology Highlights Increased Neutrophil Count in Muscle-Invasive Urothelial Carcinoma.Journal of cytologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Cervical cancer is one of the deadliest cancers that pose a significant threat to women's health. Early detection and treatment are commonly used methods to prevent cervical cancer. The use of pathological image analysis techniques for the automatic interpretation of cervical cells in pathological slides is a prominent area of research in the field of digital medicine. According to The Bethesda System, cervical cytology necessitates further classification of precancerous lesions based on positive interpretations. However, clinical definitions among different categories of lesion are complex and often characterized by fuzzy boundaries. In addition, pathologists can deduce different criteria for judgment based on The Bethesda System, leading to potential confusion during data labeling. Noisy labels due to this reason are a great challenge for supervised learning. To address the problem caused by noisy labels, we propose a method based on label credibility correction for cervical cell images classification network. Firstly, a contrastive learning network is used to extract discriminative features from cell images to obtain more similar intra-class sample features. Subsequently, these features are fed into an unsupervised method for clustering, resulting in unsupervised class labels. Then unsupervised labels are corresponded to the true labels to separate confusable and typical samples. Through a similarity comparison between the cluster samples and the statistical feature centers of each class, the label credibility analysis is carried out to group labels. Finally, a cervical cell images multi-class network is trained using synergistic grouping method. In order to enhance the stability of the classification model, momentum is incorporated into the synergistic grouping loss. Experimental validation is conducted on a dataset comprising approximately 60,000 cells from multiple hospitals, showcasing the effectiveness of our proposed approach. The method achieves 2-class task accuracy of 0.9241 and 5-class task accuracy of 0.8598. Our proposed method achieves better performance than existing classification networks on cervical cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.